Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
June 06, 2024 05:25 ET | Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
June 06, 2024 05:23 ET | Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
vle-web-logo.jpg
Valeura Wins Upstream Company of the Year and Executive of the Year Awards
June 06, 2024 05:19 ET | Valeura Energy Inc.
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) ("Valeura" or the "Company"), is pleased to announce that the Energy Council has awarded Valeura the Upstream...
Subsea 7 S.A. mandatory notification of share trades
June 06, 2024 05:19 ET | Subsea 7 (Uk Service Co) Ltd
Luxembourg – 6 June 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) announces mandatory notification of the following share transaction by a primary insider: 1Details of the person discharging...
WOO_X_Additional_s.png
WOO X Ranks Top Trading Exchange for Jeo Boden (BODEN)
June 06, 2024 05:12 ET | WOO X
VICTORIA, Seychelles, June 06, 2024 (GLOBE NEWSWIRE) -- WOO X, a leading global centralized crypto futures and spot trading platform, has solidified its position as the number one centralized spot...
mobia-logo.png
Ryan Conn Joins MOBIA as Enterprise Account Executive for Alberta
June 06, 2024 05:08 ET | MOBIA Technology Innovations
CALGARY, Alberta, June 06, 2024 (GLOBE NEWSWIRE) -- MOBIA, Canada’s leading business transformation partner, is excited to welcome Ryan Conn as Enterprise Account Executive for Alberta. A natural...
22157.jpg
Global Premenstrual Syndrome (PMS) & Menstrual Health Supplements Market Report 2024-2033: Combined Nutritional Supplements Lead the Way in $37.23 Billion PMS and Menstrual Health Market by 2033
June 06, 2024 05:02 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - A Global and Regional Analysis: Focus on Product, Indication, Formulation, Sales...
Johnson & Johnson be
Johnson & Johnson beantragt bei der Europäischen Arzneimittel-Agentur die Zulassung der subkutanen Formulierung von RYBREVANT®▼ (amivantamab) für die Behandlung von Patienten mit EGFR-mutiertem nicht-kleinzelligem Lungenkrebs
June 06, 2024 05:01 ET | Janssen Cilag International NV
Die Einreichung wird durch Daten aus der Phase-III-Studie PALOMA-3 unterstützt, die auf der Jahrestagung der American Society of Clinical Oncology (ASCO) vorgestellt wurden1 Neue Formulierung zeigte...
QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2024
June 06, 2024 05:00 ET | QuantaSing Group Limited
BEIJING, June 06, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced its unaudited...
Sagimet-Logo-for-light-bg-FIN.png
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024
June 06, 2024 05:00 ET | Sagimet Biosciences Inc.
Denifanstat achieved statistically significant results on primary and secondary liver biopsy endpoints in the ITT population, including both histology endpoints recommended in the FDA draft guidance...